FindTrial
Sign In

Outcome of Therapeutic Plasma Exchange in patients of Liver injury due to rodenticide poisoning in a tertiary care centre in Western India without Liver Transplant facility

Outcome of Therapeutic Plasma Exchange in patients of Liver injury due to rodenticide poisoning in a tertiary care centre in Western India without Liver Transplant facility - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/03/083732
Enrollment
40
Registered
2025-03-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S00-T88- Injury, poisoning and certain other consequences of external causes

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

TNMC & BYL Nair Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients who have consumed rodenticide ( phosphorous compound) presenting with a) Acute liver failure b) Acute liver injury

Exclusion criteria

Exclusion criteria: Patients not willing to participate Patients who had taken rodenticide along with other hepatotoxic agents

Design outcomes

Primary

MeasureTime frame
To assess the survival benefit of Low volume Plasma Exchange in patients of liver injury due to rodenticide poisoning (phosphorous compound).Timepoint: From the time of admission till death/ discharge.—

Secondary

MeasureTime frame
To assess the improvement in liver function tests. (Total Bilirubin, Direct Bilirubin, SGOT, SGPT, Total Protein, Albumin, Alkaline Phosphatase, INR)Timepoint: From the time of admission till death/ discharge.—

Countries

India

Contacts

Public ContactPravin Motilal Rathi

Topiwala National Medical College And Bai Yamunabai Laxman Nair Charitable Hospital

m.vishal4089@gmail.com9322406438

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026